GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company commercializing a nasal spray for the treatment of gastroparesis. Its stock price reflects slow sales growth and competition for market share in a niche market.
Share prices of companies in the market segment - Pharma git
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases, particularly gastroparesis. We've classified it in the Pharma: Gastrointestinal category. The chart below shows how investors value companies operating in niche but important areas of medicine.
Broad Market Index - GURU.Markets
Evoke Pharma is a pharmaceutical company specializing in the development of drugs for the treatment of gastrointestinal diseases. Its focus on this niche makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Evoke compares to the overall market dynamics.
Change in the price of a company, segment, and market as a whole per day
EVOK - Daily change in the company's share price Evoke Pharma Inc.
For Evoke Pharma, Inc., a pharmaceutical company, daily volatility reflects sensitivity to the commercial success of its nasal spray. This metric is an indicator of demand for its niche product and marketing effectiveness.
Daily change in the price of a set of shares in a market segment - Pharma git
Evoke Pharma specializes in gastrointestinal medications. The pharmaceutical sector, especially those with a highly specialized focus, can be highly volatile. The chart below shows average fluctuations in this niche, which helps us understand whether EVOK's stock price movements are typical for the industry.
Daily change in the price of a broad market stock, index - GURU.Markets
Evoke Pharma is a pharmaceutical company specializing in the treatment of gastrointestinal diseases. Its shares are driven by news about sales and the development of new drugs. This dynamic, specific to the pharmaceutical industry, creates fluctuations that contribute to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Evoke Pharma Inc.
Evoke Pharma, Inc.'s year-over-year performance is a story about the commercialization of its Gimoti nasal spray for the treatment of gastroparesis. Its market capitalization growth over the past 12 months reflects the sales volume of this niche product. Its valuation is a bet that its convenient delivery method will capture market share from traditional tablets.
Annual dynamics of market capitalization of the market segment - Pharma git
Evoke, a commercial pharmaceutical company, is focused on treating gastrointestinal diseases. Its success depends on the commercialization of its key drug. The chart below shows how its niche strategy and competitive environment influence its volatile performance in the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Evoke Pharma is commercializing a drug for the treatment of gastroparesis, offering a new solution for patients with this condition. A comparison of its annual market capitalization dynamics with the market demonstrates how a successful new product launch and its acceptance by the medical community impact the valuation of a small pharmaceutical company, allowing it to grow independently of overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company with a single commercial product. Its monthly growth is directly dependent on the commercial success of its Gimoti nasal spray. Quarterly reports on prescription growth and revenue are the key indicators.
Monthly dynamics of market capitalization of the market segment - Pharma git
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing drugs for the treatment of gastrointestinal diseases. The dynamics of its sector, shown in the chart, serve as background. It's interesting to see how its unique, FDA-approved nasal spray for the treatment of gastroparesis is carving out a niche in the market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its success depends on sales of its single approved product. The company's shares can move independently of the market, reacting to sales reports and insurance company coverage decisions, making its performance highly niche.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Evoke Pharma Inc.
Evoke Pharma, a pharmaceutical company with a single commercial product for the treatment of gastroparesis, is heavily dependent on its success. Weekly stock performance reflects sales reports, insurance coverage decisions, and marketing efforts, revealing how the market views the company's chances of commercialization.
Weekly dynamics of market capitalization of the market segment - Pharma git
Evoke Pharma focuses on drugs for the treatment of gastrointestinal diseases. The company's success largely depends on the commercialization of its core product. The chart helps assess whether the weekly stock price movement is related to general trends in the pharmaceutical industry or sales and marketing news.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Evoke Pharma is a pharmaceutical company with a single core product. Its stock is heavily dependent on sales data and marketing efforts. The chart below shows how much of its performance is driven by these unique factors, rather than by overall market trends.
Market capitalization of the company, segment and market as a whole
EVOK - Market capitalization of the company Evoke Pharma Inc.
Evoke Pharma's market capitalization is the investor valuation of its only commercial product. The chart shows how the market values its nasal spray, Gimoti, for the treatment of gastroparesis. Its low price reflects the challenges of commercializing a drug for a niche condition and high competition from traditional treatments.
EVOK - Share of the company's market capitalization Evoke Pharma Inc. within the market segment - Pharma git
Evoke Pharma is a small pharmaceutical company focused on treating gastrointestinal diseases. Its market share reflects its narrow focus. Its market capitalization is almost entirely dependent on the commercial success of its sole product, a nasal spray for the treatment of gastroparesis.
Market capitalization of the market segment - Pharma git
This chart shows the overall market capitalization of the entire pharmaceutical sector focused on gastrointestinal diseases. For Evoke Pharma, whose drug is designed to treat gastroparesis, this line represents a map of unmet needs. The rising chart demonstrates that even in the crowded pharmaceutical sector, there is room for companies solving specific but important medical problems.
Market capitalization of all companies included in a broad market index - GURU.Markets
Evoke Pharma has developed and markets a nasal spray for the treatment of gastroparesis. Its market capitalization is a measure of its solution to a specific medical problem. It indicates the market share a company can achieve with a single, yet in-demand, niche product.
Book value capitalization of the company, segment and market as a whole
EVOK - Book value capitalization of the company Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company that developed a nasal spray for the treatment of gastroparesis. Its book value is its financial resources and product inventory. This represents the capital for commercializing and marketing its only approved drug. How has it changed? The chart below shows this history.
EVOK - Share of the company's book capitalization Evoke Pharma Inc. within the market segment - Pharma git
Evoke Pharma, Inc. is a pharmaceutical company focused on gastroenterology. Its business, which includes the nasal spray Gimoti, requires manufacturing and logistics infrastructure for its production and distribution. The chart shows its share of the tangible assets supporting this niche pharmaceutical product.
Market segment balance sheet capitalization - Pharma git
Evoke Pharma is a pharmaceutical company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. Evoke, as a commercial company, invests not only in R&D but also in the infrastructure to sell its nasal spray.
Book value of all companies included in the broad market index - GURU.Markets
Evoke Pharma's assets are not its production lines, but primarily its intellectual property and commercial infrastructure for marketing its nasal spray for the treatment of gastroparesis. Its book value reflects the capital invested in bringing this unique product to market. The chart illustrates its scale.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company with a single commercial product. Its market capitalization reflects the current and expected sales of this drug. This is an assessment of its ability to successfully commercialize its single asset and establish a market niche.
Market to book capitalization ratio in a market segment - Pharma git
Evoke Pharma is a pharmaceutical company with a single commercial product. Its valuation on this chart is heavily dependent on the sales success of this drug and its ability to compete in the market. This reflects the difficulty of commercializing even approved drugs.
Market to book capitalization ratio for the market as a whole
Evoke Pharma develops drugs for the treatment of gastrointestinal diseases. The company's market value reflects the potential of its approved drug and future developments. This metric allows investors to assess how pharmaceutical companies with existing products are viewed by investors compared to purely research-based biotech companies.
Debts of the company, segment and market as a whole
EVOK - Company debts Evoke Pharma Inc.
Evoke Pharma, a small pharmaceutical company commercializing a drug for the treatment of gastroparesis, uses debt financing to support its marketing efforts and operations. This chart illustrates the financial challenges a single-product company faces as it ramps up sales in a competitive market.
Market segment debts - Pharma git
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases. The company is commercializing a nasal spray for the treatment of gastroparesis. This chart illustrates how a small pharmaceutical company manages its capital to fund the marketing and sales of its niche product while competing in the market and striving for profitability.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Evoke Pharma Inc.
Evoke Pharma specializes in drugs for the treatment of gastrointestinal diseases, particularly gastroparesis. Commercializing even an approved drug requires significant marketing and distribution costs. This chart shows how the company uses debt to finance its product's market launch and compete with other treatments.
Market segment debt to market segment book capitalization - Pharma git
Evoke Pharma is a small pharmaceutical company focused on gastrointestinal treatments. Commercializing even a single product is challenging. This chart shows how the company finances its operations. It compares its debt load to the market capitalization of the entire pharmaceutical sector.
Debt to book value of all companies in the market
Evoke Pharma specializes in drugs for the treatment of gastrointestinal disorders. Commercializing even a single drug requires significant marketing and sales resources. Does the company use debt to promote its product? This chart of total market debt allows you to evaluate its financial strategy and dependence on external capital.
P/E of the company, segment and market as a whole
P/E - Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. This chart shows how investors assess the commercial success of its nasal spray for gastroparesis. The assessment depends on sales volume and competition from other treatments.
P/E of the market segment - Pharma git
Evoke Pharma is a pharmaceutical company specializing in the development of drugs for the treatment of gastrointestinal diseases. Its flagship product is a nasal spray for the treatment of gastroparesis. This chart shows the average valuation in the pharmaceutical industry, where investors evaluate the potential of innovative drug delivery systems to improve treatment.
P/E of the market as a whole
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing drugs for the treatment of gastrointestinal diseases. Its main product is designed to treat gastroparesis. This chart reflects the overall sentiment in the pharmaceutical sector. It helps us understand what influences EVOK's valuation more: overall market trends or the commercial success of its niche product.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Evoke Pharma Inc.
Evoke Pharma has developed and commercialized a nasal spray for the treatment of gastroparesis in adults, offering a convenient alternative to existing treatments. The company's success depends on the acceptance of this new drug delivery method by doctors and patients. This chart shows market expectations for sales volumes and future growth of this niche pharmaceutical product.
%20P%2FE%20Evoke%20Pharma%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Evoke-Pharma-Inc.&v=1772513883455 "Chart of the company's future (projected) P/E Evoke Pharma Inc.")
Future (projected) P/E of the market segment - Pharma git
Evoke Pharma is commercializing a drug for the treatment of gastroparesis in adults. The company is focused on a single product and its successful launch. The chart compares Evoke's future revenue expectations with the industry. It helps understand the market's confidence in the commercial potential of this niche drug and the company's strategy.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-git&v=1772513883479 "Future (projected) P/E graph of the market segment - Pharma git")
Future (projected) P/E of the market as a whole
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its main product is a nasal spray for gastroparesis. This market sentiment chart helps assess investor sentiment toward companies with a single commercialized product and their growth potential.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513883496 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Evoke Pharma Inc.
Evoke Pharma, Inc. is commercializing a drug for the treatment of gastroparesis, a condition that slows or stops the movement of food out of the stomach. The company's profits are directly dependent on the sales success of this single product. This chart shows financial results, reflecting the challenges and opportunities of bringing a niche pharmaceutical to market.
Profit of companies in the market segment - Pharma git
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on developing drugs for the treatment of gastrointestinal diseases, particularly gastroparesis. This chart shows overall profitability in the gastroenterology sector, where there is a significant need for new treatments to improve the quality of life for millions of patients with chronic conditions.
Overall market profit
Evoke Pharma, Inc. specializes in medications for the treatment of gastrointestinal diseases. Demand for its products is driven by medical needs and treatment effectiveness, not by economic conditions. This makes Evoke Pharma's business unaffected by market cycles, as seen in this chart, which are typical for the pharmaceutical sector.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Evoke Pharma Inc.
Evoke Pharma is commercializing a drug for the treatment of gastroparesis in adults, administered as a nasal spray. The company's future profitability depends on sales success and the acceptance of this new delivery method by physicians and patients. This chart shows analyst expectations for the commercial potential of the company's only product on the market.
%20profit%20of%20the%20company%20Evoke%20Pharma%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Evoke-Pharma-Inc.&v=1772513883557 "Graph of future (projected) profit of the company Evoke Pharma Inc.")
Future (predicted) profit of companies in the market segment - Pharma git
Evoke Pharma specializes in gastrointestinal medications. Its key product is a nasal spray for the treatment of gastroparesis in adults. The company's success depends on the commercialization of this niche product. This chart shows profitability expectations for the pharmaceutical sector, providing context for evaluating Evoke Pharma's strategy.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-git&v=1772513883586 "Graph of future (predicted) profits of companies in a market segment - Pharma git")
Future (predicted) profit of the market as a whole
Evoke Pharma, Inc. is a pharmaceutical company specializing in gastrointestinal medications. Its commercial success depends on sales and market acceptance of its products. This economic outlook affects the overall solvency of the healthcare system and the willingness of insurers to cover new medications.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513883597 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its revenue is driven by sales of its sole commercial product. This chart shows how investors assess its market potential and the company's ability to market it effectively.
P/S market segment - Pharma git
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases. Its main product is a nasal spray for the relief of gastroparesis symptoms in adults, offering a convenient alternative to oral medications. This chart reflects the average revenue estimate for the sector, which helps assess the commercial potential of Evoke's product.
P/S of the market as a whole
Evoke Pharma is a pharmaceutical company specializing in drugs for the treatment of gastrointestinal diseases, particularly gastroparesis. The company's success depends on the commercialization of its core product. This chart helps understand how the market values highly specialized pharmaceutical companies with a single key drug compared to more diversified businesses.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its key product is a nasal spray for the treatment of gastroparesis. Estimating future revenue is important to the company. It reflects investors' assessment of the product's commercial potential, its ability to gain market share, and its potential to become a preferred treatment option for patients.
%20P%2FS%20Evoke%20Pharma%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Evoke-Pharma-Inc.&v=1772513883659 "The graph of the company's future (projected) P/S Evoke Pharma Inc.")
Future (projected) P/S of the market segment - Pharma git
Evoke Pharma specializes in developing medications for gastrointestinal diseases. Its key product is a nasal spray for the relief of gastroparesis symptoms in adults. This chart reflects how investors view the company's future revenue relative to the pharmaceutical sector. It demonstrates the market's confidence in the commercial success of its unique drug delivery system.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20git&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-git&v=1772513883664 "Future (projected) P/S market segment graph - Pharma git")
Future (projected) P/S of the market as a whole
Evoke Pharma specializes in the treatment of gastrointestinal diseases, having developed a nasal spray for patients with gastroparesis. The company's success depends on the successful commercialization of its sole product. This graph of investor expectations reflects their view of the pharmaceutical market and the potential of niche drugs.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513883701 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Evoke Pharma Inc.
This chart shows Evoke Pharma, Inc.'s revenue, generated from sales of its sole commercial product—GIMOTI nasal spray for the treatment of gastroparesis in adults. The growth of this metric directly reflects the company's success in promoting its drug to physicians and patients suffering from this condition.
Sales of companies in the market segment - Pharma git
Evoke Pharma, Inc. is a pharmaceutical company specializing in gastrointestinal diseases. Its revenue is generated by sales of GIMOTI, a nasal spray for the treatment of gastroparesis in women. The sales structure demonstrates the market success of this innovative delivery method.
Overall market sales
Evoke Pharma, Inc. specializes in medications for the treatment of gastrointestinal diseases. Demand for its products is driven by patient needs, making it non-cyclical. This overall market performance chart serves only as a backdrop for a company operating in the healthcare sector, where drug efficacy and safety are paramount.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Evoke Pharma Inc.
Evoke Pharma, Inc. is a specialty pharmaceutical company focused on the treatment of gastrointestinal diseases. Its primary product is a nasal spray for the treatment of gastroparesis. Revenue growth depends on the successful commercialization of this drug. This chart shows analyst sales expectations, reflecting their assessment of patient and physician demand.
%20sales%20of%20the%20company%20Evoke%20Pharma%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Evoke-Pharma-Inc.&v=1772513883785 "Schedule of future (projected) sales of the company Evoke Pharma Inc.")
Future (projected) sales of companies in the market segment - Pharma git
Evoke Pharma offers a drug for the treatment of gastroparesis in adults, administered via nasal spray. This chart shows the forecast for the gastrointestinal drug market. Is demand growing for new, more convenient forms of medications for chronic conditions? This reflects the overall trend toward improving quality of life for patients in this area.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-git&v=1772513883803 "Schedule of future (projected) sales of companies in the market segment - Pharma git")
Future (projected) sales of the market as a whole
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Demand for its products is driven by medical needs, doctor prescriptions, and insurance coverage. The overall economic situation, reflected in this chart, has minimal impact on treatment decisions for chronic gastrointestinal diseases.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513883840 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases. Its key product is a nasal spray for patients with gastroparesis. This chart shows how successfully the company is commercializing its niche drug. Profitability is directly dependent on sales volume and the acceptance of this new drug delivery method by doctors and patients.
Market segment marginality - Pharma git
Evoke Pharma, Inc. is a pharmaceutical company specializing in gastrointestinal medications. Its primary product is a nasal spray for the treatment of gastroparesis. The company's profitability depends on successful sales of this product, its acceptance by physicians and patients, and the competitive environment. This metric reflects its commercial efforts and operational efficiency.
Market marginality as a whole
Evoke Pharma is commercializing a drug for the treatment of gastroparesis. The company's success depends on its acceptance by doctors and patients, as well as insurance coverage. This overall profitability chart reflects the state of the healthcare system, which during periods of economic pressure may be less inclined to approve new, more expensive drugs.
Employees in the company, segment and market as a whole
Number of employees in the company Evoke Pharma Inc.
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases. After receiving approval for its nasal spray, it expanded its sales team. This timeline shows how the company moved from R&D to commercialization, which required hiring marketing and sales specialists to promote the product.
Share of the company's employees Evoke Pharma Inc. within the market segment - Pharma git
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal treatments. Following approval for its product, the company is building its commercial infrastructure. This graph shows its labor market share, and its growth may reflect the company's transition from R&D to active sales and marketing, which requires new personnel.
Number of employees in the market segment - Pharma git
Evoke Pharma specializes in the treatment of gastrointestinal diseases, particularly gastroparesis. The company has developed a nasal spray for delivering metoclopramide. The chart illustrates employment in the gastroenterology pharmaceutical sector. Evoke's innovative delivery method solves the problem of oral medication administration for patients with impaired gastric motility.
Number of employees in the market as a whole
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its commercial success depends on the acceptance of its products by doctors and patients. This chart shows the overall picture, and Evoke is an example of a niche pharmaceutical company whose market growth is determined by the effectiveness of one or more key drugs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Evoke Pharma Inc. (EVOK)
Evoke Pharma is a specialty pharmaceutical company focused on treating gastrointestinal diseases (for example, their product Gimoti). Unlike R&D giants, their model is more focused on commercialization. This graph shows the market value per employee, reflecting how the market values their existing product and the effectiveness of their small commercial team.
%20of%20the%20company%20Evoke%20Pharma%20Inc.%20(EVOK)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Evoke-Pharma-Inc.-EVOK&v=1772513884072 "Chart of market capitalization per employee (in thousands of dollars) of the company Evoke Pharma Inc. (EVOK)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma git
Evoke Pharma (EVOK) specializes in drugs for the treatment of gastrointestinal diseases, particularly gastroparesis. For a pharmaceutical company with a narrow focus, this metric reflects the commercial potential of its product. An increase in this metric may be associated with regulatory approval and the successful launch of the drug, which is what investors value.
%20by%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-git&v=1772513884086 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma git")
Market capitalization per employee (in thousands of dollars) for the overall market
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal medications. Its value is closely tied to the commercial success of its product. This metric reflects how the market assesses its sales potential and the ability of its small sales team to effectively promote the drug to doctors and patients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513884129 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Evoke Pharma Inc. (EVOK)
Evoke Pharma is a pharmaceutical company focused on treating gastrointestinal diseases. The company has a commercial product (nasal spray). This chart shows how successfully the company is commercializing its drug. It reflects how much net profit its small sales and marketing team generates from selling this highly specialized product.
%20Chart%20Evoke%20Pharma%20Inc.%20(EVOK)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Evoke-Pharma-Inc.-EVOK&v=1772513884130 "Company Profit Per Employee (in thousands of dollars) Chart Evoke Pharma Inc. (EVOK)")
Profit per employee (in thousands of dollars) in the market segment - Pharma git
Evoke Pharma, Inc. focuses on drugs for gastrointestinal diseases. In the pharmaceutical industry, even a small team can generate significant profits after a drug is approved. This chart shows how effectively the company monetizes its intellectual property and how this metric compares to competitors in its therapeutic niche.
%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-git&v=1772513884159 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma git")
Profit per employee (in thousands of dollars) for the market as a whole
Evoke Pharma is a pharmaceutical company focused on gastrointestinal diseases. Their product (Gimoti) is a nasal spray for the treatment of gastroparesis. It's a niche pharmaceutical. Their model isn't R&D from scratch, but rather marketing and sales of an already approved product. This chart helps understand how a commercial pharmaceutical company with a small staff compares to the market in terms of revenue per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513884248 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Evoke Pharma Inc. (EVOK)
Evoke Pharma is a pharmaceutical company focused on gastrointestinal treatments. This chart measures the commercial success of their products. The increase in revenue per employee after the drug's launch demonstrates its popularity among doctors and patients and the effectiveness of their small sales team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Evoke-Pharma-Inc.-EVOK&v=1772513884322 "Sales chart per company employee Evoke Pharma Inc. (EVOK)")
Sales per employee in the market segment - Pharma git
Evoke Pharma is a pharmaceutical company focused on gastrointestinal diseases. Their flagship product is Gimoti, a nasal spray for the treatment of gastroparesis. This chart shows the average revenue for the sector. For EVOK, this is an indicator of how productive their small sales team is in promoting and selling this highly niche drug.
Sales per employee for the market as a whole
Evoke Pharma is a pharmaceutical company that has already reached the commercial stage. Their product is a nasal spray for the treatment of gastroparesis. This indicator demonstrates the effectiveness of their business model. It reflects how successfully their small but focused sales and marketing team is promoting this niche drug to doctors and patients.
Short shares by company, segment and market as a whole
Shares shorted by company Evoke Pharma Inc. (EVOK)
Evoke Pharma (EVOK) has one commercial product—a nasal spray for the treatment of gastroparesis (a stomach condition). This chart shows the volume of bearish bets. The shorts may reflect the product's weak launch, and investors don't believe it can capture market share from existing, cheaper oral medications.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Evoke-Pharma-Inc.-EVOK&v=1772513884419 "Short Shares Chart for the Company Evoke Pharma Inc. (EVOK)")
Shares shorted by market segment - Pharma git
Evoke Pharma (EVOK) is a pharmaceutical company specializing in the treatment of gastrointestinal diseases. Its flagship product is Gimoti, a nasal spray for the treatment of gastroparesis. This chart shows the total short position in the specialty pharmaceuticals sector. It reflects investor concerns about the commercial success of niche drugs.
Shares shorted by the overall market
Evoke (EVOK) is a clinical-stage biotech company. Its value is based on future expectations. When this market fear indicator rises, investors' risk appetite evaporates. They are the first to sell speculative, loss-making biotechs like EVOK in favor of safer assets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Evoke Pharma Inc. (EVOK)
Evoke Pharma (EVOK) is commercializing Gimoti, a nasal spray for the treatment of gastroparesis in diabetics, which eliminates the need to take pills when experiencing nausea. This indicator measures trend strength. It shows when the stock is "overheated" (above 70) due to positive sales reports or "oversold" (below 30) due to slow physician adoption.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Evoke-Pharma-Inc.-EVOK&v=1772513884501 "RSI 14 indicator chart for the company's stock Evoke Pharma Inc. (EVOK)")
RSI 14 Market Segment - Pharma git
Evoke Pharma is a pharmaceutical company specializing in gastrointestinal diseases. Its sole product, Gimoti, is a nasal spray for the treatment of gastroparesis in diabetics. This chart shows the overall sentiment in the gastrointestinal pharmaceutical sector. It helps us understand whether EVOK's momentum is driven by its commercial success or is a general "wave" across the industry.
RSI 14 for the overall market
Evoke Pharma (EVOK) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EVOK (Evoke Pharma Inc.)
Evoke Pharma is a pharmaceutical company focused on a single product: GIMOTI. It is an intranasal spray for the treatment of gastroparesis (a condition affecting stomach motility) in diabetics. This chart shows the average price target from analysts, which is almost entirely dependent on their sales volume and prescription growth forecasts for GIMOTI.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EVOK-Evoke-Pharma-Inc.&v=1772513884662 "A chart showing analyst consensus forecasts for the expected stock price. EVOK (Evoke Pharma Inc.)")
The difference between the consensus estimate and the actual stock price EVOK (Evoke Pharma Inc.)
Evoke Pharma is a pharmaceutical company focused on the gastrointestinal tract. Their flagship product (Gimoti) is a nasal spray for the treatment of gastroparesis (stomach paralysis) in diabetics. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their view on the commercial success of this niche drug.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EVOK-Evoke-Pharma-Inc.&v=1772513884767 "A chart showing the difference between the consensus forecast and the actual stock price. EVOK (Evoke Pharma Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma git
Evoke (EVOK) is a pharmaceutical company selling a niche drug (Gimoti, a nasal spray) for the treatment of gastroparesis. Its goal is to convince doctors to use their product instead of older medications. This chart shows analysts' overall expectations for the entire specialty pharmaceutical sector. It reflects whether experts believe niche drugs will be commercially successful or whether they believe the market is dominated by giants.
Analysts' consensus forecast for the overall market share price
Evoke Pharma is a specialty pharmaceutical company whose main product is a nasal spray (Gimoti) for the treatment of gastroparesis (an indigestion disorder). This is a healthcare sector often considered defensive. This chart shows overall market sentiment. For Evoke, as a company in the commercialization stage, overall optimism is important, as it facilitates the funding needed for marketing.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Evoke Pharma Inc.
Evoke is a one-bet pharmaceutical company. Their only approved product (Gimoti) is a nasal spray (not a pill) for the treatment of gastroparesis (stomach paralysis) in diabetics. This chart is a summary of their commercialization history. It reflects their (very slow) sales growth rate, their cash burn, and their struggle to convince doctors and insurers of the value of their niche product.
AKIMA Market Segment Index - Pharma git
Evoke Pharma (EVOK) is a single-product company solving the problem of diabetic gastroparesis (stomach paralysis). Their unique product is GIMOTI, the first and only nasal spray containing metoclopramide. They have focused on a new delivery method for patients who have difficulty swallowing tablets. This graph shows the average index for the segment, which helps assess how successful this niche strategy is compared to the average.
The AKIM Index for the overall market
Evoke Pharma is a specialty pharmaceutical company focused on the treatment of gastroparesis (Gimoti is a nasal spray). This chart, reflecting the market average, provides a macro backdrop. It helps assess how this niche product's commercial performance compares to overall economic trends.
